SEC Form 4 · accession 0001415889-19-000322
Vistagen Therapeutics, Inc. · VTGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jon S Saxe
Director
Period of report
Mar 13, 2019
Accepted (ET)
Mar 14, 2019 · 5:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001411685
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 13, 2019 | P | 12,080 | $1.2584 | A | 12,080 | I | By the Jon S. Saxe and Myrna G. Marshall 1997 Trust |
| Common Stock | Mar 14, 2019 | P | 7,920 | $1.2735 | A | 20,000 | I | By the Jon S. Saxe and Myrna G. Marshall 1997 Trust |
| Common Stock | holding | — | — | — | 3,251 | D |
Table II — derivative securities
No Table II lines on this filing.